Duliege Anne-Marie 4
4 · RIGEL PHARMACEUTICALS INC · Filed Jul 5, 2018
Insider Transaction Report
Form 4
Duliege Anne-Marie
Chief Medical Officer
Transactions
- Sale
Common Stock
2018-07-02$2.79/sh−5,000$13,932→ 0 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26,2018.
- [F2]The Reporting Person purchased these shares on June 29, 2018 under the Issuer's Employee Stock Purchase Plan.
- [F3]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions ranging from $2.76 to $2.80. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each such separate price.